Astex and Fujisawa announce structure-based drug discovery agreement
25-Aug-2003 -
Cambridge, UK and Osaka, Japan. Astex Technology Ltd, the fragment-based drug discovery company, and Fujisawa Pharmaceutical Co., Ltd, announced a structural biology research agreement to facilitate the rapid design and development of drug candidates. The collaboration will focus on solving novel ...
Complexation
drug development
Japan
+3